Company No: 12025898 (England and Wales)

Contents

• Statement of Financial Position
• Notes to the Financial Statements

		2025		2024
		£		£
Fixed assets		2,606		1,594
Current assets		4,821		21,685
Prepayments and accrued income		479,175		277,093
Creditors: amounts falling due within one year		( 129,465)		( 77,774)
Net current assets		354,531		221,004
Total assets less current liabilities		357,137		222,598
Accruals and deferred income		( 4,600)		( 7,425)
Net assets		352,537		215,173
Capital and reserves		352,537		215,173

For the financial year ending 31 May 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Income Statement has not been delivered.

The financial statements of Rothermed Ltd (registered number: 12025898) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

A J Samuels Director

29 May 2026

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12025898). The address of its registered office is Cowfields Farm, Rotherfield Greys, Henley On Thames, RG9 4PX, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	-		-

3. Directors’ benefits: advances, credit and guarantees

Advances

At the reporting date, the company was due £nil (2024 - £10,935) from the directors.